Were way past wt loss as the key efficacy benchmark, and we need more benefits beyond the scale. Yulia Lurye, MD
Currently, some GLP-1 medications are only FDA-approved to manage blood sugar levels or reduce cardiovascular risk in people with type 2 diabetes, like Ozempic and Mounjaro
The chromatogram won't show it
GLP-1 Drugs Are Closing In on Surgery
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, play a crucial role in glucose metabolism by enhancing the glucose-dependent secretion of insulin from pancreatic beta cells and inhibiting glucagon release from alpha cells, thus lowering blood glucose levels postprandially (Holst, 2007)
These prices can make long-term treatment difficult to maintain, especially when insurance coverage is limited or unpredictable for weight loss treatments